NSC |
Compound |
Enrichment |
Correlation |
NSC 732962 |
5-amino-4-(1,3-benzothiazol-2-yl)-1-(2-chloro-5-trifluoromet hylphenyl)-2,3-dihydro-1H-3-pyrrolone |
0.0329129886465389 |
0.16825286 |
NSC 734949 |
4-[3-(3,4-dihydro-1H-isoquinolin-2-yl)prop-1-en-2-yl]-N-pyrazin-2-ylbenzamide |
0.0329129886465389 |
0.29010241 |
NSC 132791 |
Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo |
0.0375780807984386 |
0.24849435 |
NSC 133118 |
2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) |
0.0375780807984386 |
0.039461185 |
NSC 134459 |
Acetamide, N-(2-mercaptoethyl)-, benzoate (6CI, 7CI) |
0.0375780807984386 |
0.25351502 |
NSC 149765 |
1,4-Pentanediamine, N4-(6-methoxy-8-quinolinyl)-, phosphate (1:2) (9CI) |
0.0375780807984386 |
0.24799003 |
NSC 252628 |
1H-Purine, 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)seleno]- |
0.0375780807984386 |
0.23694866 |
NSC 295499 |
Camptothecin Derivative |
0.0375780807984386 |
0.26212093 |
NSC 319947 |
2,4-Pyrimidinediamine, 5-(3-azido-4-chlorophenyl)-6-ethyl- |
0.0375780807984386 |
0.028878985 |
NSC 349174 |
Oxanthrazole |
0.0375780807984386 |
0.086834349 |